8. REFERENCES
  1. Teachey DT, Hunger SP, Loh ML. Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia. Blood . 2021;137(2):168-177. doi:10.1182/blood.2020007702
  2. Koren G, Ferrazini G, Sulh H, et al. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med . 1990;323(1):17-21. doi:10.1056/NEJM199007053230104
  3. Bhatia S, Landier W, Shangguan M, et al. Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children’s oncology group. J Clin Oncol . 2012;30(17):2094-2101. doi:10.1200/JCO.2011.38.9924
  4. Brackett J, Schafer ES, Leung DH, Bernhardt MB. Use of allopurinol in children with acute lymphoblastic leukemia to reduce skewed thiopurine metabolism. Pediatr Blood Cancer . 2014;61(6):1114-1117. doi:10.1002/pbc.24913
  5. Purixan (mercaptopurine) [package insert]. Memphis, TN: AnovoRx Distribution LLC; 1953.
  6. Adam de Beaumais T, Jacqz-Aigrain E. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia. Eur J Clin Pharmacol. 2012;68(9):1233-1242. doi:10.1007/s00228-012-1251-4
  7. Cohen G, Cooper S, Sison EA, Annesley C, Bhuiyan M, Brown P. Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6-mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity. Pediatr Blood Cancer. 2020;67(11):e28360. doi:10.1002/pbc.28360
  8. Stuckert AJ, Schafer ES, Bernhardt MB, Baxter P, Brackett J. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL). Leuk Lymphoma. 2020;61(5):1246-1249. doi:10.1080/10428194.2019.1702183
  9. Vasta LM, Zanetti RC, Parekh DS, Warwick AB, Lieuw K. A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients With Suboptimal Metabolites Successfully Corrected With Allopurinol. J Pediatr Hematol Oncol . 2021;43(7):e1003-e1009. doi:10.1097/MPH.0000000000001939
  10. Conneely SE, Cooper SL, Rau RE. Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia. Front Oncol . 2020;10:1129. Published 2020 Jul 16. doi:10.3389/fonc.2020.01129
  11. Wickham, H. (2016). Ggplot2: Elegant graphics for data analysis  (2nd ed.) [PDF]. Springer International Publishing.
  12. Allen LV Jr, Erickson MA 3rd. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids. Am J Health Syst Pharm . 1996;53(16):1944-1949. doi:10.1093/ajhp/53.16.1944